Search

Your search keyword '"de Klippel, N."' showing total 41 results

Search Constraints

Start Over You searched for: Author "de Klippel, N." Remove constraint Author: "de Klippel, N."
41 results on '"de Klippel, N."'

Search Results

1. Effect of the Factor XIa Inhibitor Asundexian According to Baseline Infarct Pattern and on MRI Covert Infarct Outcomes

2. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

3. A European Observational Study to Evaluate the Safety and the Effectiveness of Safinamide in Routine Clinical Practice: The SYNAPSES Trial

4. A European observational study to evaluate the safety and the effectiveness of safinamide in routine clinical practice: The SynapSES trial

8. Loss of DPP6 in neurodegenerative dementia: a genetic player in the dysfunction of neuronal excitability

9. Loss of DPP6 in neurodegenerative dementia: a genetic player in the dysfunction of neuronal excitability

11. Rivaroxaban for stroke prevention after embolic stroke of undetermined source

12. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

13. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

14. The European Stroke Scale

15. Vorapaxar in the secondary prevention of atherothrombotic events

16. Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study

18. Organisation of inhospital acute stroke care and minimum criteria for stroke care units. Recommendations of the Belgian Stroke Council

28. Burden of migraine in patients attending Belgian headache specialists: real-world evidence from the BECOME study.

29. Effectiveness and safety of safinamide in routine clinical practice in a Belgian Parkinson's disease population: an open-label, levodopa add-on study.

30. Neurological outcome after minimally invasive coronary artery bypass surgery (NOMICS): An observational prospective cohort study.

31. Clinical variability and onset age modifiers in an extended Belgian GRN founder family.

33. A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial.

34. Fluoxetine in progressive multiple sclerosis (FLUOX-PMS): study protocol for a randomized controlled trial.

35. Organisation of inhospital acute stroke care and minimum criteria for stroke care units. Recommendations of the Belgian Stroke Council.

36. Survey to evaluate diagnosis and management of headache in primary care: Headache Management Pattern programme.

37. Early outcome in acute ischemic stroke is not influenced by the prophylactic use of low-dose aspirin.

38. Tonic GABA-ergic modulation of striatal dopamine release studied by in vivo microdialysis in the freely moving rat.

39. Bromocriptine therapy in multiple sclerosis: an open label pilot study.

40. Effect of M1- and M2-muscarinic drugs on striatal dopamine release and metabolism: an in vivo microdialysis study comparing normal and 6-hydroxydopamine-lesioned rats.

41. Progressive paraparesis due to thoracic extramedullary hematopoiesis in myelofibrosis. Case report.

Catalog

Books, media, physical & digital resources